A cyclase V Antibodies

Santa Cruz Biotechnology delivers a wide array of A cyclase V monoclonal antibodies for research in understanding this important signaling molecule. A cyclase V monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). A cyclase V, also known as soluble guanylate cyclase, plays a crucial role in the nitric oxide signaling pathway, which is vital for regulating vascular tone and neurotransmission. By converting GTP to cGMP, A cyclase V influences various physiological processes, including smooth muscle relaxation and neuronal signaling. Understanding A cyclase V function is essential for elucidating its involvement in cardiovascular health and neurobiology. Research has shown that A cyclase V significantly impacts blood pressure regulation and neural plasticity. Investigating A cyclase V expression patterns and activity levels can provide valuable insights into cardiovascular disorders and neurological conditions. Recent studies have highlighted A cyclase V's potential as a therapeutic target in treating hypertension and neurological diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of A cyclase V's role in human health and disease.